AXSM Axsome Therapeutics, Inc.
Healthcare$235.97+1.00%ClosedMarket Cap: $12.14B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$255.81
Target (Median)
$259.50
Target Range
$200.00 - $302.00
Upside from current price: 8.4%
Rating Distribution
3 Strong Buy17 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-05 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-05 | Guggenheim | maintain | Buy | Buy |
| 2026-05-05 | Needham | maintain | Buy | Buy |
| 2026-05-05 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-05 | Morgan Stanley | maintain | Equal Weight | Equal Weight |
| 2026-05-05 | Mizuho | maintain | Outperform | Outperform |
| 2026-05-05 | Baird | maintain | Outperform | Outperform |
| 2026-05-05 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-05-04 | Jefferies | maintain | Buy | Buy |
| 2026-04-10 | UBS | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $5.78 | $1.60B | 13 |
| Sun Dec 31 | $14.40 | $2.28B | 16 |
| Mon Dec 31 | $24.56 | $3.09B | 14 |
| Tue Dec 31 | $31.49 | $3.76B | 14 |